Denmark· DK-28106369319

Copiktra

A duvelisib product containing duvelisib monohydrat, registered in Denmark by Secura Bio Limited. The same ATC class is registered in 6 of our 19 countries.

ATC L01EM04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedCopiktraATCL01EM04REGISTER NO.DK-28106369319PACKS LISTED1CHECKEDSeptember 2, 2026

Where it is registered

Duvelisib is registered in 6 of 19 countries.

Countries holding a registration under ATC L01EM04 (duvelisib), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 4 of them publish a price we can compare per daily dose

Duvelisib · ATC L01EM04

6 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Duvelisib MONOHYDRAT
Manufacturer
Secura Bio Limited
Country
Denmark (DK)
ATC code
L01EM04
ATC class
Duvelisib
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 2, 2026

Packs & prices · 1

  • dk_varenummer
    28106369319

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

313 interactions on record for duvelisib.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Duvelisib · interactions on record

313 records

  • 71 severe
  • 234 moderate
  • 8 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • EliglustatA16AX10severe
  • CilostazolB01AC23severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/404430c5-efd1-48aa-8b5e-5c70d541cd04
GET /v1/drugs/404430c5-efd1-48aa-8b5e-5c70d541cd04?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "kapsler, hårde",
  "source": "dkma",
  "strength": "15 mg",
  "auth_role": "RAP",
  "dk_drugid": "28106369319",
  "substance": "Duvelisib MONOHYDRAT",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "44335"
}

See everything about duvelisib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.